Plant Medicine Facilitation & Psychedelic Prep/Integration

Light to support the depth of work and as a sober psychedelic alternative

The Lucia N°03 does not compete with plant medicine. It completes it.

For facilitators working with psilocybin, ketamine, ayahuasca, MDMA, or any consciousness-expanding medicine, the Lucia N°03 offers something the field has long needed: a legal, above-ground, pharmacology-free tool that produces altered states of comparable neurological character to the medicines you work with. It can be used before a session, after it, or entirely in place of substances for clients who cannot or should not work with pharmacological approaches.

 

WHERE THE LUCIA N°03 FITS IN YOUR PRACTICE

Before the medicine session: PREPARATION

A client who enters a medicine session unfamiliar with altered states, or whose nervous system is primed for resistance rather than receptivity, is significantly less likely to have a therapeutically productive experience.

One to three Lucia N°03 sessions in the weeks before a medicine experience does several things at once. It familiarizes the client with what it actually feels like when cognitive defenses soften and inner imagery begins to arise, which transforms the unknown into something they have already navigated. It primes the nervous system toward the parasympathetic-dominant, low-default-mode-network state in which medicine is most therapeutically bioavailable.

Additionally, it gives you, as the facilitator, a window into how this particular client relates to expanded states before the irreversibility of a medicine session begins.

The 2025 Oxford review on stroboscopic light explicitly identifies SLS as a preparatory tool for psychedelic-assisted therapy, noting that it allows a patient to familiarize themselves with altered state experiences while retaining the option of immediate termination if discomfort arises. OVID Clinics in Berlin are currently using stroboscopic light sessions as preparation before ketamine-assisted therapy in a clinical setting.

 

After the medicine session: INTEGRATION

Integration is where psychedelic therapy either succeeds or stalls. The insights and emotional releases that occur during a medicine session need somewhere to land.

The Lucia N°03 is well suited to this work because it operates in the same phenomenological register as the medicine session itself. Where verbal integration works at the level of language and meaning, a Lucia N°03 session continues working at the level of imagery, sensation, and somatic pattern. Clients frequently report that a light session in the days following a medicine experience helps them re-enter and complete material that arose but was not fully processed, without requiring another pharmacological event to get there.

 

For clients who cannot work with substances: A safe alternative

SSRI and SNRI antidepressants, the most commonly prescribed psychiatric medications in the United States, significantly blunt the therapeutic effects of psilocybin and MDMA. Clients managing certain cardiovascular conditions, bipolar disorder, or a personal or family history of psychosis face genuine barriers to substance-based work. Clients in professional roles with drug testing requirements cannot access substances even where legal.

The Lucia N°03 has no pharmacological interaction with any medication. A client on long-term SSRIs experiences the light with the same quality of interior access as any other client. For practitioners whose clients most need psychedelic-level work and are least able to access it pharmacologically, the Lucia N°03 is not a workaround. It is a primary offering.

 

WHAT THE SCIENCE NOW SAYS

The research on stroboscopic light and psychedelic states has moved well past preliminary. A few findings particularly relevant to this clinical context:

Schwartzman et al. at the University of Sussex conducted the foundational study specifically with the Lucia N°03, measuring neural signal diversity during sessions and finding results comparable to psilocybin, concluding the light may function as an alternative or adjunct to psychedelic therapy.

Bartossek et al. at Freie Universität Berlin established formal psychometric equivalence between flicker light stimulation and pharmacological altered states, finding visual imagery ratings comparable to 100 micrograms of LSD, with minimal negative effects.

Montgomery, Amaya and Schmidt, published in Frontiers in Psychology in 2024, found that stroboscopic light significantly enhanced emotional responses to music in ways that parallel psychedelic experiences, with meaningful overlap in ego dissolution and altered time perception, while fear and paranoia remained largely absent.

Most recently, a 2025 study in Molecular Brain from Bar Ilan University found that psilocybin and light exposure produce similar and synergistic effects on gene expression in the visual cortex. This is not just experiential similarity. Light and psychedelic substances appear to be working through overlapping biological mechanisms at the molecular level, and the implications for combined therapeutic protocols are only beginning to be understood.

In March 2026, Freie Universität Berlin hosted the 2nd International Symposium on Stroboscopic Light, bringing together researchers and clinicians from across the world to examine clinical applications of stroboscopic light. This is a field moving toward institutional legitimacy, not retreating from it.

Full citations and study downloads are at lucialightexperience.com/pages/the-science

 

THE NEUROPSYCHOLYSIS CONNECTION

The Lucia N°03 was not adapted for psychedelic work. It was designed for it.

Drs. Winkler and Proeckl named their clinical framework Neuropsycholysis precisely because of its lineage in psycholytic therapy, the tradition of using psychedelic substances to dissolve fixed mental structures developed by Stanislav Grof and others. The Lucia N°03 follows the same therapeutic arc: induce a therapeutically relevant expansion of consciousness, accompany the client through it within a skilled relational container, support integration of what arises.

The critical addition for facilitators trained in this work: because the altered state is generated by a device rather than a substance, you can interact with your client in real time throughout the entire session. You can deepen, soften, redirect, or stop the experience immediately. The therapeutic relationship does not pause while the altered state is active. It operates fully within it.

The MIND Foundation's Augmented Psychotherapy Training, one of the most credentialed psychedelic therapy certification programs in Europe, explicitly lists stroboscopic light alongside psilocybin and atypical psychedelic substances as a valid non-pharmacological method for inducing altered states in psychedelic-augmented psychotherapy.

 

WANT TO GO DEEPER?

Download our eBook for plant medicine facilitators, which covers the full preparation and integration protocols, the complete research base, clinical case scenarios, and how to structure this offering alongside your existing medicine practice.

Download the eBook →

Schedule a Call with Allison →